Improvement in health outcomes with GLP-1RA in patients with overweight or obesity with CVD Medical Education on ReachMD

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details

Presenters

Overview
AHA 2023 As discussant of the SELECT trial, Ania Jastreboff reviews the results. She points out that it is critical to treat obesity. Not only to achieve weight reduction, but also to improve health outcomes.
Educational information
This video was recorded during the AHA Scientific Sessions 2023 in Philadelphia, PA, USA.
Faculty
Ania Jastreboff, MD, PhD is an Associate Professor in Medicine and Pediatrics at Yale School of Medicine in New Haven, CT, USA. She is the director of the Yale Obesity Research Center and co-director of the Yale Center for Weight Management.
Disclosures
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.
Read a summary of the SELECT trial
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Recommended

Details

Presenters

Overview
AHA 2023 As discussant of the SELECT trial, Ania Jastreboff reviews the results. She points out that it is critical to treat obesity. Not only to achieve weight reduction, but also to improve health outcomes.
Educational information
This video was recorded during the AHA Scientific Sessions 2023 in Philadelphia, PA, USA.
Faculty
Ania Jastreboff, MD, PhD is an Associate Professor in Medicine and Pediatrics at Yale School of Medicine in New Haven, CT, USA. She is the director of the Yale Obesity Research Center and co-director of the Yale Center for Weight Management.
Disclosures
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.
Read a summary of the SELECT trial
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Improvement in health outcomes with GLP-1RA in patients with overweight or obesity with CVD